Deep Brain Stimulation Devices Market Size, Share, and Growth Analysis, By Product Type (Single-channel DBS Devices, Dual-channel DBS Devices), By Application (Epilepsy, Pain Management), By End User, By Region - Industry Forecast 2025-2032
뇌심부 자극(DBS) 기기 세계 시장 규모는 2023년 15억 4,000만 달러로 평가되었습니다. 2024년 16억 8,000만 달러에서 2032년에는 34억 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 9.2%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 뇌심부 자극 기기 시장은 파킨슨병 및 본태성 진전증과 같은 신경질환의 유병률 증가와 효과적인 치료 솔루션에 대한 수요 증가로 인해 견조한 성장세를 보이고 있습니다. 수명이 긴 충전식 장치와 타겟팅 시스템의 개선 등 DBS 기술의 발전으로 시술의 효과와 안전성이 향상되고 있으며, DBS가 신뢰할 수 있는 치료법으로 받아들여지고 환자와 의료진의 인식이 높아진 것도 시장 확대에 크게 기여하고 있습니다. 선진국의 우호적인 상환 정책과 신흥국 시장의 헬스케어 투자 확대는 제조업체의 성장 기회를 더욱 촉진하고 있습니다. 전반적으로, 이러한 요인들이 수렴함에 따라 DBS 장치 시장은 향후 몇 년동안 큰 발전을 이룰 것으로 보입니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 기술 분석
- 규제 분석
뇌심부 자극 기기 시장 규모 : 제품 유형별
- 시장 개요
- 싱글 채널 DBS 기기
- 듀얼 채널 DBS 기기
뇌심부 자극 기기 시장 규모 : 용도별
- 시장 개요
- 간질
- 통증 관리
- 본태성 진전
- 강박성 장애(OCD)
- 파킨슨병
- 우울증
- 근육긴장이상
- 기타
뇌심부 자극 기기 시장 규모 : 최종사용자별
- 시장 개요
- 병원
- 신경과 클리닉
- 외래수술센터(ASC)
- 연구센터
- 기타
뇌심부 자극 기기 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 전년대비 매출 비교(2022-2024년)
주요 기업 개요
- Medtronic Plc.(USA)
- Abbott Laboratories(USA)
- Boston Scientific Corporation(USA)
- Aleva Neurotherapeutics S.A.(Switzerland)
- Beijing PINS Medical Co., Ltd.(China)
- Brainsway Ltd.(USA)
- NeuroPace Inc.(USA)
- Functional Neuromodulation Ltd.(USA)
- NeuroSigma, Inc.(USA)
- Beijing Pinchi Medical Equipment Co., Ltd.(China)
- SceneRay Corporation Ltd.(China)
- Sapiens Steering Brain Stimulation(Netherlands)
- Renishaw plc(UK)
- Synapse Biomedical Inc.(USA)
- Deep Brain Innovations LLC(USA)
- Newronika S.p.A.(Italy)
- Nexstim Plc(Finland)
- Neuronetics, Inc.(USA)
- Magstim Company Limited(UK)
- Bioinduction Ltd.(UK)
결론과 제안
LSH
Global Deep Brain Stimulation Devices Market size was valued at USD 1.54 billion in 2023 and is poised to grow from USD 1.68 billion in 2024 to USD 3.4 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).
The global deep brain stimulation (DBS) device market is experiencing robust growth, driven by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor, which has intensified the demand for effective treatment solutions. Advances in DBS technology, including longer-lasting rechargeable devices and improved targeting systems, have enhanced procedural efficacy and safety. Increased acceptance of DBS as a credible treatment, along with heightened awareness among patients and healthcare professionals, contributes significantly to market expansion. Favorable reimbursement policies in developed regions and escalating healthcare investments in emerging markets are further propelling growth opportunities for manufacturers. Overall, the convergence of these factors positions the DBS device market for substantial advancement in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Deep Brain Stimulation Devices Market Segments Analysis
Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Deep Brain Stimulation Devices Market
The Global Deep Brain Stimulation Devices market is primarily driven by innovations in technology that have markedly enhanced patient outcomes and broadened the array of conditions that can be effectively treated. Key advancements include the creation of highly accurate targeting systems and refined stimulation parameters, alongside the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological improvements facilitate personalized treatment regimens, optimize symptom management, and lessen potential side effects, thereby strengthening the overall efficacy and safety of deep brain stimulation therapy. As a result, the market is experiencing robust growth fueled by these transformative developments.
Restraints in the Global Deep Brain Stimulation Devices Market
The global deep brain stimulation devices market faces significant restraints primarily due to the complexity of these devices, which necessitate precise implantation surgeries conducted by highly skilled neurosurgeons. The overall expenses associated with these devices-encompassing the hardware, leads, and programming systems-can be quite high. Furthermore, the costs associated with the surgical procedure increase as they require specialized equipment, operating room facilities, and extensive post-operative care. This high financial burden presents a barrier to affordability and accessibility, particularly in regions where healthcare resources are scarce or insurance coverage is insufficient, limiting the market's potential growth.
Market Trends of the Global Deep Brain Stimulation Devices Market
The Global Deep Brain Stimulation (DBS) Devices market is witnessing significant growth, largely fueled by the rising prevalence of neurological disorders, particularly among the aging population. Conditions such as Parkinson's disease, essential tremor, and dystonia are becoming increasingly common due to factors like chronic disease proliferation and exposure to environmental toxins. As awareness about DBS as a highly effective treatment option spreads, there is a marked increase in demand for these devices. This trend underscores a shifting focus towards innovative surgical interventions in neurology, positioning the DBS market for robust expansion in the coming years.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Technology Analysis
- Regulatory Analysis
Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2025-2032)
- Market Overview
- Single-channel DBS Devices
- Dual-channel DBS Devices
Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2025-2032)
- Market Overview
- Epilepsy
- Pain Management
- Essential Tremor
- Obsessive Compulsive Disorder (OCD)
- Parkinson's Disease
- Depression
- Dystonia
- Others
Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2025-2032)
- Market Overview
- Hospitals
- Neurology Clinics
- Ambulatory Surgical Centers
- Research Centers
- Others
Global Deep Brain Stimulation Devices Market Size & CAGR (2025-2032)
- North America (Product Type, Application, End User)
- Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Medtronic Plc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aleva Neurotherapeutics S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beijing PINS Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainsway Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Functional Neuromodulation Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroSigma, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beijing Pinchi Medical Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SceneRay Corporation Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sapiens Steering Brain Stimulation (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Renishaw plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synapse Biomedical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Deep Brain Innovations LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Newronika S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nexstim Plc (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neuronetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Magstim Company Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioinduction Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
